241 related articles for article (PubMed ID: 31301340)
1. Tumor-specific delivery of gemcitabine with activatable liposomes.
Tucci ST; Kheirolomoom A; Ingham ES; Mahakian LM; Tam SM; Foiret J; Hubbard NE; Borowsky AD; Baikoghli M; Cheng RH; Ferrara KW
J Control Release; 2019 Sep; 309():277-288. PubMed ID: 31301340
[TBL] [Abstract][Full Text] [Related]
2. Can intracellular drug delivery using hyaluronic acid functionalised pH-sensitive liposomes overcome gemcitabine resistance in pancreatic cancer?
Tang M; Svirskis D; Leung E; Kanamala M; Wang H; Wu Z
J Control Release; 2019 Jul; 305():89-100. PubMed ID: 31096017
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine treatment of rat soft tissue sarcoma with phosphatidyldiglycerol-based thermosensitive liposomes.
Limmer S; Hahn J; Schmidt R; Wachholz K; Zengerle A; Lechner K; Eibl H; Issels RD; Hossann M; Lindner LH
Pharm Res; 2014 Sep; 31(9):2276-86. PubMed ID: 24599802
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies.
Tang Z; Feng W; Yang Y; Wang Q
Drug Des Devel Ther; 2019; 13():3281-3290. PubMed ID: 31571830
[TBL] [Abstract][Full Text] [Related]
5. Smart thermosensitive liposomes for effective solid tumor therapy and in vivo imaging.
Affram K; Udofot O; Singh M; Krishnan S; Reams R; Rosenberg J; Agyare E
PLoS One; 2017; 12(9):e0185116. PubMed ID: 28934281
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs.
Immordino ML; Brusa P; Rocco F; Arpicco S; Ceruti M; Cattel L
J Control Release; 2004 Dec; 100(3):331-46. PubMed ID: 15567500
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine-loaded Folic Acid Tagged Liposomes: Improved Pharmacokinetic and Biodistribution Profile.
Unnam S; Panduragaiah VM; Sidramappa MA; Muddana Eswara BR
Curr Drug Deliv; 2019; 16(2):111-122. PubMed ID: 30360740
[TBL] [Abstract][Full Text] [Related]
8. A Liposomal Gemcitabine, FF-10832, Improves Plasma Stability, Tumor Targeting, and Antitumor Efficacy of Gemcitabine in Pancreatic Cancer Xenograft Models.
Matsumoto T; Komori T; Yoshino Y; Ioroi T; Kitahashi T; Kitahara H; Ono K; Higuchi T; Sakabe M; Kori H; Kano M; Hori R; Kato Y; Hagiwara S
Pharm Res; 2021 Jun; 38(6):1093-1106. PubMed ID: 33961188
[TBL] [Abstract][Full Text] [Related]
9. PEG-Benzaldehyde-Hydrazone-Lipid Based PEG-Sheddable pH-Sensitive Liposomes: Abilities for Endosomal Escape and Long Circulation.
Kanamala M; Palmer BD; Ghandehari H; Wilson WR; Wu Z
Pharm Res; 2018 May; 35(8):154. PubMed ID: 29855807
[TBL] [Abstract][Full Text] [Related]
10. In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer.
Cosco D; Bulotta A; Ventura M; Celia C; Calimeri T; Perri G; Paolino D; Costa N; Neri P; Tagliaferri P; Tassone P; Fresta M
Cancer Chemother Pharmacol; 2009 Oct; 64(5):1009-20. PubMed ID: 19263052
[TBL] [Abstract][Full Text] [Related]
11. Temperature-sensitive magnetic drug carriers for concurrent gemcitabine chemohyperthermia.
Kim DH; Guo Y; Zhang Z; Procissi D; Nicolai J; Omary RA; Larson AC
Adv Healthc Mater; 2014 May; 3(5):714-24. PubMed ID: 24574255
[TBL] [Abstract][Full Text] [Related]
12. Thermosensitive gemcitabine-magnetoliposomes for combined hyperthermia and chemotherapy.
Ferreira RV; Martins TM; Goes AM; Fabris JD; Cavalcante LC; Outon LE; Domingues RZ
Nanotechnology; 2016 Feb; 27(8):085105. PubMed ID: 26820520
[TBL] [Abstract][Full Text] [Related]
13. Development of high-content gemcitabine PEGylated liposomes and their cytotoxicity on drug-resistant pancreatic tumour cells.
Xu H; Paxton J; Lim J; Li Y; Zhang W; Duxfield L; Wu Z
Pharm Res; 2014 Oct; 31(10):2583-92. PubMed ID: 24639234
[TBL] [Abstract][Full Text] [Related]
14. Effective light-triggered contents release from helper lipid-incorporated liposomes co-encapsulating gemcitabine and a water-soluble photosensitizer.
Fuse T; Tagami T; Tane M; Ozeki T
Int J Pharm; 2018 Apr; 540(1-2):50-56. PubMed ID: 29410222
[TBL] [Abstract][Full Text] [Related]
15. pH-Sensitive Nanoparticles Composed Solely of Membrane-Disruptive Macromolecules for Treating Pancreatic Cancer.
Fan F; Jin L; Yang L
ACS Appl Mater Interfaces; 2021 Mar; 13(11):12824-12835. PubMed ID: 33689289
[TBL] [Abstract][Full Text] [Related]
16. A novel gemcitabine derivative-loaded liposome with great pancreas-targeting ability.
Li PW; Luo S; Xiao LY; Tian BL; Wang L; Zhang ZR; Zeng YC
Acta Pharmacol Sin; 2019 Nov; 40(11):1448-1456. PubMed ID: 31015736
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Loading Strategies to Improve Tumor Uptake of Gemcitabine in a Murine Orthotopic Bladder Cancer Model Using Ultrasound and Microbubbles.
Ruan JL; Browning RJ; Yildiz YO; Bau L; Kamila S; Gray MD; Folkes L; Hampson A; McHale AP; Callan JF; Vojnovic B; Kiltie AE; Stride E
Ultrasound Med Biol; 2021 Jun; 47(6):1596-1615. PubMed ID: 33707089
[TBL] [Abstract][Full Text] [Related]
18. PEGylated liposomal Gemcitabine: insights into a potential breast cancer therapeutic.
Papa AL; Sidiqui A; Balasubramanian SU; Sarangi S; Luchette M; Sengupta S; Harfouche R
Cell Oncol (Dordr); 2013 Dec; 36(6):449-57. PubMed ID: 24081907
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of gemcitabine liposome injections.
Zhou Q; Liu L; Zhang D; Fan X
Pharmazie; 2012 Oct; 67(10):844-7. PubMed ID: 23136718
[TBL] [Abstract][Full Text] [Related]
20. Development of Liposomal Gemcitabine with High Drug Loading Capacity.
Tamam H; Park J; Gadalla HH; Masters AR; Abdel-Aleem JA; Abdelrahman SI; Abdelrahman AA; Lyle LT; Yeo Y
Mol Pharm; 2019 Jul; 16(7):2858-2871. PubMed ID: 31136710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
